Simultaneous population pharmacokinetic modelling of darunavir and ritonavir Once daily in HIV-infected patients: evaluation of lower ritonavir dose

被引：0
|
作者：
Dickinson, L. [1 ]
Jackson, A. [2 ]
Garvey, L. [3 ]
Watson, V [1 ]
Khoo, S. [1 ]
Winston, A. [3 ]
Boffito, M. [2 ]
Davies, G. [1 ]
Back, D. [1 ]
机构：
[1] Univ Liverpool, Dept Mol & Clin Pharmacol, Pharmacol Res Labs, Liverpool L69 3BX, Merseyside, England
[2] Chelsea & Westminster Fdn Trust, St Stephens Ctr, London, England
[3] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept HIV & GU Med, London, England
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2012年 / 15卷
关键词：
D O I：
10.7448/IAS.15.6.18331
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [1] Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals
    Arab-Alameddine, M.
    Lubomirov, R.
    Fayet-Mello, A.
    Aouri, M.
    Rotger, M.
    Buclin, T.
    Widmer, N.
    Gatri, M.
    Ledergerber, B.
    Rentsch, K.
    Cavassini, M.
    Panchaud, A.
    Guidi, M.
    Telenti, A.
    Decosterd, L. A.
    Csajka, C.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (09) : 2489 - 2498
  • [2] Simultaneous Pharmacogenetics-Based Population Pharmacokinetic Analysis of Darunavir and Ritonavir in HIV-Infected Patients
    José Moltó
    George Xinarianos
    Cristina Miranda
    Sudeep Pushpakom
    Samandhy Cedeño
    Bonaventura Clotet
    Andrew Owen
    Marta Valle
    Clinical Pharmacokinetics, 2013, 52 : 543 - 553
  • [3] Simultaneous Pharmacogenetics-Based Population Pharmacokinetic Analysis of Darunavir and Ritonavir in HIV-Infected Patients
    Molto, Jose
    Xinarianos, George
    Miranda, Cristina
    Pushpakom, Sudeep
    Cedeno, Samandhy
    Clotet, Bonaventura
    Owen, Andrew
    Valle, Marta
    CLINICAL PHARMACOKINETICS, 2013, 52 (07) : 543 - 553
  • [4] Plasma and Intracellular Pharmacokinetics of Darunavir/Ritonavir Once Daily and Raltegravir Once and Twice Daily in HIV-Infected Individuals
    Jackson, Akil
    Watson, Victoria
    Back, David
    Khoo, Saye
    Liptrott, Neill
    Egan, Deidre
    Gedela, Keerti
    Higgs, Chris
    Abbas, Riaz
    Gazzard, Brian
    Boffito, Marta
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 58 (05) : 450 - 457
  • [5] Treatment simplification to once daily darunavir/ritonavir guided by the darunavir inhibitory quotient in heavily pretreated HIV-infected patients
    Molto, Jose
    Valle, Marta
    Ramon Santos, Jose
    Mothe, Beatriz
    Miranda, Cristina
    Cedeno, Samandhy
    Negredo, Eugenia
    Yritia, Mercedes
    Videla, Sebastian
    Jose Barbanoj, Manuel
    Clotet, Bonaventura
    ANTIVIRAL THERAPY, 2010, 15 (02) : 219 - 225
  • [6] Simultaneous Population Pharmacokinetic Modelling of Atazanavir and Ritonavir in HIV-Infected Adults and Assessment of Different Dose Reduction Strategies
    Schipani, Alessandro
    Dickinson, Laura
    Boffito, Marta
    Austin, Rupert
    Owen, Andrew
    Back, David
    Khoo, Saye
    Davies, Gerry
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 62 (01) : 60 - 66
  • [7] Simultaneous Population Pharmacokinetic Model for Lopinavir and Ritonavir in HIV-Infected Adults
    José Moltó
    Manuel José Barbanoj
    Cristina Miranda
    Asunción Blanco
    José Ramón Santos
    Eugenia Negredo
    Joan Costa
    Pere Domingo
    Bonaventura Clotet
    Marta Valle
    Clinical Pharmacokinetics, 2008, 47 : 681 - 692
  • [8] Simultaneous population pharmacokinetic model for lopinavir and ritonavir in HIV-infected adults
    Molto, Jose
    Barbanoj, Manuel Jose
    Miranda, Cristina
    Blanco, Asuncion
    Santos, Jose Ramon
    Negredo, Eugenia
    Costa, Joan
    Domingo, Pere
    Clotet, Bonaventura
    Valle, Marta
    CLINICAL PHARMACOKINETICS, 2008, 47 (10) : 681 - 692
  • [9] Pharmacokinetic profile of maraviroc 150 mg dosed with darunavir/ritonavir once daily, with and without nucleoside analogues, in HIV-infected subjects
    Mora-Peris, B.
    Croucher, A.
    Else, L.
    Khoo, S.
    Vera, J.
    Back, D.
    Winston, A.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 56 - 57
  • [10] Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in adarunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study
    Le, Minh P.
    Chaix, Marie-Laure
    Chevret, Sylvie
    Bertrand, Julie
    Raffi, Francois
    Gallien, Sebastien
    El Abbassi, El Mountacer Billah
    Katlama, Christine
    Delobel, Pierre
    Yazdanpanah, Yazdan
    Saillard, Juliette
    Molina, Jean-Michel
    Peytavin, Gilles
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (08) : 2120 - 2128
12345